Agout Febuxostat is a xanthine oxidase inhibitor used to treat hyperuricemia in patients with gout. By inhibiting xanthine oxidase, Agout Febuxostat reduces the production of uric acid, leading to lower serum uric acid levels. This helps prevent gout flares and the formation of urate crystals in joints and tissues. Clinical studies have shown that Agout Febuxostat effectively lowers serum uric acid levels and reduces the frequency of gout attacks. It is an important treatment option for patients with gout to manage their condition and improve quality of life.